Abstract:270 Background: Radiotracers used in prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging have high specificity for the detection of prostate cancer (PCa), and PSMA PET/CT imaging has seen increased use in the management of localized PCa. However, the diagnostic capability of PSMA PET can be limited by intense uptake in the ureters, bladder, and urethra due to physiologic urinary excretion. Specifically, radiotracer activity in the prostatic urethra can be misinterpreted as a midline intraprostatic lesion if not carefully evaluated with morphologic imaging. This study aimed to elucidate the correlation between positive 18 F-DCFPyL activity in the midline prostate with hyperintense signal on T2-weighted MRI (T2W MRI) within the prostatic urethra as an indication of retained urine. Methods: Ninety-seven patients received both 18 F-DCFPyL PSMA PET/CT and 3 Tesla prostate MRI post-void imaging for localized, high-risk PCa. Patients with prior prostate treatment (i.e., surgery, androgen deprivation therapy, or radiotherapy) or poor prostatic urethra visualization (i.e., PCa involving the whole gland, Foley catheter in situ) were excluded, resulting in a final cohort of 84 patients. Radiotracer activity in the midline region of the prostate was prospectively evaluated by two nuclear medicine physicians during PET/CT read outs. Post-void T2W MRI scans were retrospectively evaluated for the presence of residual urine noted as hyperintensity within the prostatic urethral lumen by one genitourinary radiologist blinded to PET/CT evaluations. The corresponding prostatic urethra diameters were measured on both axial and sagittal T2W MRI. Fisher’s exact test and Mann-Whitney U tests were used to compare MRI and PET/CT findings. Results: In 84 patients, midline activity on PSMA PET imaging was documented in 16 patients (the case group), whereas the remaining 68 patients without midline activity constituted the control group. In total, 75% (12/16) and 31% (21/68) of patients in the case and control groups, respectively, had urethral hyperintensity on T2W MRI (p < .01, Fisher’s exact test). In patients with a hyperintense urethral lumen at MRI, there was a significant difference in mean prostatic urethral measurements between the case and control groups in both axial (7.25 mm vs. 2.81 mm, p < .0001, Mann Whitney U) and sagittal (12.25 mm vs. 5.43 mm, p < .0001, Mann Whitney U) planes. Conclusions: Our findings suggest that PSMA uptake within the midline of the prostate is more commonly observed in patients with a prominently visible prostatic urethra at MRI, a finding that is likely associated with the stagnation of urine containing PSMA tracer. This midline uptake may be prone to misinterpretation as a potential PCa lesion on PSMA PET/CT, and the use of post-void MRIs may be useful in reducing the likelihood of false positive interpretations of PSMA PET/CT.

Increase 68Ga-Fapi Uptake in Urogenital Tuberculosis

Case report: Systemic tuberculosis with prostate involvement mimicking prostate cancer with multiple metastases on 18F-FDG and 18F-PSMA PET/CT

Increased Uptake of 68 Ga-DOTA-IBA in Multiple Subcutaneous Metastases of Prostate Cancer

Liver tuberculosis presenting as an uncommon cause of pyrexia of unknown origin: positron emission tomography/computed tomography identifies the correct site for biopsy.

68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor

Increased FAPI Activity in Pulmonary Tuberculosis

68Ga-Fapi and 18F-PET/CT Images in Intestinal Tuberculosis.

An exploratory study of unexplained concentration of 18F-PSMA-1007 in the bladder for prostate cancer PET/CT imaging

Incidental Uptake of 68 Ga-DOTA-IBA in Prostate Adenocarcinoma.

Asymptomatic Prostate Cancer Metastasis in Rectal Mucosa Revealed by 18 F-PSMA-1007 PET/CT

A Single-Center, Multi-Factor, Retrospective Study to Improve the Diagnostic Accuracy of Primary Prostate Cancer Using [68Ga]ga-Psma-11 Total-Body PET/CT Imaging.

Multiformity of 18 F-FDG PET Findings in Tuberculosis

Non-tumoral uptake of 68Ga-FAPI-04 PET: A retrospective study

Primary Solitary Tuberculosis in the Hepatic Round Ligament Detected by 68Ga-FAPI PET/CT

68Ga-PSMA-11 PET Identified Tumor Recurrence in Prostatectomy Bed With Rising PSA of 0.9 ng/mL but Negative on MRI and 18F-Fluciclovine PET Scan

Optimal Time Point for 68Ga-PSMA-11 PET/CT Imaging in the Assessment of Suspected Metastatic Prostate Cancer in the Bladder of Postprostatectomy Patient

Uptake of 68Ga-DOTA-FAPI-04 in a Case of Gynecomastia

Effect of urinary stagnation in the prostatic urethra on generating false-positive midline lesions on 18 F-DCFPyL PSMA PET/CT.

Use of F-18 FDG PET/CT Through Delayed Diuretic Imaging for Preoperative Evaluation of Upper Urinary Tract-Occupying Lesions

Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging

Elevated 68Ga-Fapi Activity in Klebsiella Pneumoniae Invasion Syndrome